Merck stock heads into the open after a 1.3 percent gain
Published on 09/16/2026 at 07:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Merck stock closed at USD 144.11 on the NYSE on September 15, 2026, up 1.3 percent from the prior session. The session range ran from USD 142.25 to USD 144.50, and the stock stayed below the recent 52-week high near USD 156.92.
September 15, 2026 in numbers
Merck & Co. (ISIN US58933Y1055, NYSE: MRK) finished the session inside a narrow band after a dividend-related ex-date and a conference update kept attention on the shares. On the same day, the stock was due to trade ex-dividend for a quarterly cash payout of USD 0.85 per share, as Ad-hoc-News reported on September 15, 2026.
The shares also stayed several percent under the 52-week high near USD 156.92 while remaining far above the 52-week low of USD 77.58, according to a market note from Ad-hoc-News. The same report said the company used the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 to discuss pipeline progress and a longer-term revenue ambition, and it also cited RBC Capital's Hold rating with a USD 150 target price.
Today before the open
Merck's next visible market driver is the ex-dividend process, which remains relevant for income-focused investors on the second session after the cut-off date. Broader healthcare and market sentiment can also matter today, including the session tone in US equities after the previous close.
